Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
cyclin-dependent kinase inhibitor |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
1809773-34-5
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:hasMolecularFormula |
C23H25N7O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
umbraliciclib
|
| gptkbp:isApprovedDrug |
true
|
| gptkbp:molecularWeight |
431.49 g/mol
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:PF-06873600
|
| gptkbp:target |
gptkb:CDK2
gptkb:CDK4 gptkb:CDK6 |
| gptkbp:usedInClinicalTrialsFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:Class_I_PI3K
|
| gptkbp:bfsLayer |
5
|